β Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ SEC Filings
Date accepted | Link | Final link |
---|---|---|
2025-04-23 19:39:59 | SCHEDULE 13G/A | SCHEDULE 13G/A final |
2025-04-03 06:05:06 | 6-K | 6-K final |
2025-03-31 06:00:08 | 6-K | 6-K final |
2025-03-10 07:58:12 | 6-K | 6-K final |
2025-02-27 10:58:55 | 6-K | 6-K final |
2025-02-10 10:09:13 | ***** | ***** |
2025-02-07 08:27:37 | ***** | ***** |
2025-02-06 07:36:55 | ***** | ***** |
2025-02-05 07:18:03 | ***** | ***** |
2025-02-05 07:11:37 | ***** | ***** |
2025-02-05 07:04:21 | ***** | ***** |
2025-02-05 06:09:16 | ***** | ***** |
2025-02-04 09:24:46 | ***** | ***** |
2025-01-27 09:01:03 | ***** | ***** |
2025-01-24 07:16:15 | ***** | ***** |

π Explore more SEC filings for Novo Nordisk!
Sign up for free or log inπ Join now to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" at no cost